[go: up one dir, main page]

WO2002002755A3 - Regulation d'enzyme de type thimet oligopeptidase humaine - Google Patents

Regulation d'enzyme de type thimet oligopeptidase humaine Download PDF

Info

Publication number
WO2002002755A3
WO2002002755A3 PCT/EP2001/007634 EP0107634W WO0202755A3 WO 2002002755 A3 WO2002002755 A3 WO 2002002755A3 EP 0107634 W EP0107634 W EP 0107634W WO 0202755 A3 WO0202755 A3 WO 0202755A3
Authority
WO
WIPO (PCT)
Prior art keywords
enzyme
thimet oligopeptidase
regulation
human thimet
human
Prior art date
Application number
PCT/EP2001/007634
Other languages
English (en)
Other versions
WO2002002755A2 (fr
Inventor
Shyam Ramakrishnan
Original Assignee
Bayer Ag
Shyam Ramakrishnan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Shyam Ramakrishnan filed Critical Bayer Ag
Priority to AU2001281950A priority Critical patent/AU2001281950A1/en
Publication of WO2002002755A2 publication Critical patent/WO2002002755A2/fr
Publication of WO2002002755A3 publication Critical patent/WO2002002755A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

L'invention concerne des réactifs qui permettent de réguler une enzyme de type thimet oligopeptidase humaine et des réactifs qui se lient aux produits génétiques de cette enzyme, qui peuvent jouer un rôle de prévention, d'amélioration ou de correction de dysfonctionnements ou maladies comprenant, sans y être limitées, les maladies cancéreuses et neurodégénérescentes, telles que la maladie d'Alzheimer.
PCT/EP2001/007634 2000-07-05 2001-07-04 Regulation d'enzyme de type thimet oligopeptidase humaine WO2002002755A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001281950A AU2001281950A1 (en) 2000-07-05 2001-07-04 Regulation of human thimet oligopeptidase-like enzyme

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21635400P 2000-07-05 2000-07-05
US60/216,354 2000-07-05

Publications (2)

Publication Number Publication Date
WO2002002755A2 WO2002002755A2 (fr) 2002-01-10
WO2002002755A3 true WO2002002755A3 (fr) 2002-08-22

Family

ID=22806716

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/007634 WO2002002755A2 (fr) 2000-07-05 2001-07-04 Regulation d'enzyme de type thimet oligopeptidase humaine

Country Status (2)

Country Link
AU (1) AU2001281950A1 (fr)
WO (1) WO2002002755A2 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8968198B2 (en) 2006-02-22 2015-03-03 Dexcom, Inc. Analyte sensor
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
US9357951B2 (en) 2009-09-30 2016-06-07 Dexcom, Inc. Transcutaneous analyte sensor

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US7946984B2 (en) 2004-07-13 2011-05-24 Dexcom, Inc. Transcutaneous analyte sensor
US20110024043A1 (en) 2009-07-02 2011-02-03 Dexcom, Inc. Continuous analyte sensors and methods of making same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424205A (en) * 1990-10-05 1995-06-13 Athena Neurosciences, Inc. Amyloidin protease and uses thereof
US5883241A (en) * 1995-09-05 1999-03-16 Celltech Therapeutics Limited DNA sequences coding for a human metalloproteinase and variants thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424205A (en) * 1990-10-05 1995-06-13 Athena Neurosciences, Inc. Amyloidin protease and uses thereof
US5883241A (en) * 1995-09-05 1999-03-16 Celltech Therapeutics Limited DNA sequences coding for a human metalloproteinase and variants thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EM_EST [online] EMBL; 5 October 1998 (1998-10-05), NCI-CGAP: "qb79a03.x1 Soares_fetal_heart_NbHH19W Homo sapiens cDNA clone IMAGE:1706284 3' similar to SW:MEPD_HUMAN P52888 THIMET OLIGOPEPTIDASE ;, mRNA sequence.", XP002196340, Database accession no. AI160888 *
DATABASE MEPD_HUMAN [online] SWALL; "THIMET OLIGOPEPTIDASE (EC 3.4.24.15) (ENDOPEPTIDASE 24.15) (MP78).", Database accession no. P52888 *
KOIKE H ET AL: "THIMET OLIGOPEPTIDASE CLEAVES THE FULL-LENGTH ALZHEIMER AMYLOID PRECURSOR PROTEIN AT A BETA-SECRETASE CLEAVAGE SITE IN COS CELLS", JOURNAL OF BIOCHEMISTRY, JAPANESE BIOCHEMICAL SOCIETY, TOKYO, JP, vol. 126, no. 1, 1999, pages 235 - 242, XP000914809, ISSN: 0021-924X *
THOMPSON A ET AL: "CLONING AND FUNCTIONAL EXPRESSION OF A METALLOENDOPEPTIDASE FROM HUMAN BRAIN WITH THE ABILITY TO CLEASE A BETA-APP SUBSTRATE PEPTIDE", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 213, no. 1, 4 August 1995 (1995-08-04), pages 66 - 73, XP000651365, ISSN: 0006-291X *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
US8968198B2 (en) 2006-02-22 2015-03-03 Dexcom, Inc. Analyte sensor
US9357951B2 (en) 2009-09-30 2016-06-07 Dexcom, Inc. Transcutaneous analyte sensor

Also Published As

Publication number Publication date
WO2002002755A2 (fr) 2002-01-10
AU2001281950A1 (en) 2002-01-14

Similar Documents

Publication Publication Date Title
WO2002004610A3 (fr) Regulation d'une enzyme humaine du type dipeptidyl-peptidase iv
WO2002070675A3 (fr) Regulation de l'histone acetyltransferase humaine
WO2002002755A3 (fr) Regulation d'enzyme de type thimet oligopeptidase humaine
WO2002061092A3 (fr) Regulation de la lysyl oxydase humaine
WO2002020731A3 (fr) Regulation de l'enzyme humaine du type proteine disulfide isomerase
WO2002048325A3 (fr) Regulation de la serine palmitoyltransferase humaine
WO2001077149A3 (fr) Regulation d'une proteine gpcr type cyslt2 humaine
WO2002024878A3 (fr) Regulation d'enzyme du type proteine ubiquitine ligase (e3) humaine
WO2002055712A3 (fr) Regulation de l'alanine aminotransferase humaine
WO2002081705A3 (fr) Regulation de la proteine humaine de type acetyltransferase gnat
WO2001092310A3 (fr) Regulation de l'enzyme de type transcetolase humaine
WO2002006454A3 (fr) Regulation d'une enzyme humaine de type carboxylesterase
WO2002052016A3 (fr) Regulation d'enzyme de type proteine l-isoaspartate o-methyltransferase humaine
WO2002030969A3 (fr) Regulation une enzyme humaine de type carboxyesterase
WO2002033097A3 (fr) Regulation de la sulfotransferase humaine
WO2002062974A3 (fr) Regulation de la proteine humaine elongase hselo1
WO2002026945A3 (fr) Regulation d'une enzyme humaine de type aminotransferase
WO2002018567A3 (fr) Regulation d'enzyme humaine de type aminotransferase
WO2002018552A8 (fr) Regulation d'enzyme humaine de type aminotransferase
WO2002004608A3 (fr) Regulation de l'enzyme similaire a l'oligopeptidase a humaine
WO2002051996A3 (fr) Regulation de proteine humaine du type cyclophiline
WO2002036613A3 (fr) Regulation de la proteine humaine de type 'patched'
WO2002036781A3 (fr) Regulation de la glutathione-s-transferase humaine
WO2002000703A3 (fr) Regulation de l'enzyme de type glutamyl-arnt (gln) amido-transferase humaine
WO2002052020A3 (fr) Regulation de carboxypeptidase a humaine

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP